AG-013736, a multi-target tyrosine kinase receptor inhibitor, demonstrates anti-tumor activity in a Phase 2 study of cytokine-refractory, metastatic renal cell cancer (RCC) Meeting Abstract
| Authors: | Rini, B.; Rixe, O.; Bukowski, R.; Michaelson, M. D.; Wilding, G.; Hudes, G.; Bolte, O.; Steinfeldt, H.; Reich, S. D.; Motzer, R. |
| Abstract Title: | AG-013736, a multi-target tyrosine kinase receptor inhibitor, demonstrates anti-tumor activity in a Phase 2 study of cytokine-refractory, metastatic renal cell cancer (RCC) |
| Meeting Title: | 41st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 23 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2005 May 13-17 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2005-06-01 |
| Start Page: | 380S |
| Language: | English |
| ACCESSION: | WOS:000230326602340 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2005.23.16_suppl.4509 |
| Notes: | --- - Meeting Abstract: 4509 - 41st Annual Meeting of the American-Society-of-Clinical-Oncology - MAY 13-17, 2005 - Orlando, FL - S - Part 1 - "Source: Wos" |
